Overview
The Intensive Course in Genomic Cancer Risk Assessment — Self-Directed 2026-2027 Course is a continuing medical education (CME) accredited certificate program for Physicians, Physician Assistants, Genetic Counselors, Master's or PhD in genetics or Advanced Practice Nurses, and Geneticists. This experiences include 13 bundles of distance learning, which is then followed by four days of in-person Clinical Skills Workshops to translate course experience in clinical practice. Topics include pedigree documentation, basics in genetic counseling for cancer risk, interpreting complex test results, as well as evidence-based content related to hereditary predisposition to breast, gynecologic, gastrointestinal, genitourinary, endocrine, and pediatric cancers. Tap into the world-class faculty from City of Hope and from distinguished institutions across the nation. Learn from inter-professional cancer genomics experts to acquire the skills and knowledge you need to succeed in the rapidly-evolving field of clinical cancer genomics.
Why should you participate in this program?
- Reinforce or expand your knowledge in genetic cancer risk assessment
- Support your clinical practice with evidence-based genetic cancer risk assessment skills
- Learn to identify and manage patients with hereditary predisposition to cancer
Program Structure
- Virtual, self-directed 13-course-bundle curriculum to be completed within a 12-month period
- In-person clinical skills development workshops
- View recorded learning modules from our expert faculty
- Test your knowledge by completing quizzes and assignments
- Complete a series of required feedback evaluations
